Diarachidonoylphosphoethanolamine induces necrosis/necroptosis of malignant pleural mesothelioma cells

Cellular Signalling

Volumn 27, Issue 9, 2015, Pages 1713-1719

  Kaku, Yoshiko ^a   Tsuchiya, Ayako ^a   Kanno, Takeshi ^a   Nakano, Takashi ^a   Nishizaki, Tomoyuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Diarachidonoylphosphoethanolamine; Malignant pleural mesothelioma cell; Mitochondria; Necroptosis; Necrosis

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLOPHILIN D; CYCLOSPORIN A; DIARACHIDONOYLPHOSPHOETHANOLAMINE; LIPOCORTIN 5; NECROSTATIN 1; PHOSPHATIDYLETHANOLAMINE; PROPIDIUM IODIDE; PROTEIN KINASE INHIBITOR; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; RECEPTOR INTERACTING PROTEIN 1; UNCLASSIFIED DRUG; 1,2-DIARACHIDONOYL-GLYCERO-3-PHOSPHOETHANOLAMINE; TUMOR PROTEIN;

ARTICLE; CELL CYCLE ASSAY; CELL DEATH; CELL POPULATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; INTRACELLULAR SPACE; MESOTHELIOMA CELL LINE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; NECROPTOSIS; PHOSPHOLIPID MEMBRANE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; S PHASE CELL CYCLE CHECKPOINT; CELL SURVIVAL; DRUG EFFECTS; HUMAN; MESOTHELIOMA; METABOLISM; NECROSIS; PATHOLOGY; PLEURAL NEOPLASMS;

CELL SURVIVAL; HUMANS; MESOTHELIOMA; NECROSIS; NEOPLASM PROTEINS; PHOSPHATIDYLETHANOLAMINES; PLEURAL NEOPLASMS;

EID: 84930655330     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.05.007     Document Type: Article

References (16)

1. Degterev A., Huang Z., Boyce M., Li Y., Jagtap P., Mizushima N., Cuny G.D., Mitchison T.J., Moskowitz M.A., Yuan J. Nat. Chem. Biol. 2005, 1:112-119.
2. Christofferson D.E., Yuan J. Curr. Opin. Cell Biol. 2010, 22:263-268.
3. Li H., Zhu H., Xu C.J., Yuan J. Cell 1998, 94:491-501.
4. Kvansakul M., Hinds M.G. Cell Death Dis. 2013, 4. (e909).
5. Zong W.X., Thompson C.B. Genes Dev. 2006, 20:1-15.
6. Griffiths E.J., Halestrap A.P. Biochem. J. 1995, 307:93-98.
7. Deeba F., Tahseen H.N., Sharad K.S., Ahmad N., Akhtar S., Saleemuddin M., Mohammad O. Biochim. Biophys. Acta 2005, 1669:170-181.
8. Emoto K., Kobayashi T., Yamaji A., Aizawa H., Yahara I., Inoue K., Umeda M. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:12867-12872.
9. Emoto K., Toyama-Sorimachi N., Karasuyama H., Inoue K., Umeda M. Exp. Cell Res. 1997, 232:430-434.
10. Ichimura Y., Kirisako T., Takao T., Satomi Y., Shimonishi Y., Ishihara N., Mizushima N., Tanida I., Kominami E., Ohsumi M., Noda T., Ohsumi Y. Nature 2000, 408:488-492.
11. Yaguchi T., Nagata T., Nishizaki T. Behav. Brain Funct. 2010, 6:52.
12. Kaku Y., Tsuchiya A., Kanno T., Nakano T., Nishizaki T. Anticancer Res. 2014, 34:1759-1764.
13. Tsuchiya A., Kanno T., Nishizaki T. Cell. Physiol. Biochem. 2014, 34:617-627.
14. Vanags D.M., Pörn-Ares M.I., Coppola S., Burgess D.H., Orrenius S. J. Biol. Chem. 1996, 271:31075-31085.
15. Pietra G., Mortarini R., Parmiani G., Anichini A. Cancer Res. 2001, 61:8218-8226.
16. Vaseva A.V., Marchenko N.D., Ji K., Tsirka S.E., Holzmann S., Moll U.M. Cell 2012, 149:1536-1548.